Seeking an experienced Full Stack Engineer to join the Agriculture and Health product teams. You will plan, develop, test, deploy, and maintain high-quality, scalable products aligned with product ...

Technological trends are often short-lived and have no lasting effect. New programming languages show up every year, promising faster builds and simpler syntax. Although many competitors have entered ...

Learn how to use advanced techniques like short-circuiting, parallel execution, virtual threads, and stream gatherers to maximize Java stream performance. My recent Java Stream API tutorial introduced ...

The Trump administration's Gold Card visa can now be yours, Commerce Secretary Howard Lutnick said, arguing that the new immigration program will bring renewed investment and ideas from top talent ...

The last time I wrote an article on Structure Therapeutics Inc. (GPCR) it was in a Seeking Alpha article entitled "Structure Therapeutics: Potential To Have Best-In-class GLP-1 Agonist For Obesity ...

(NEXSTAR) – Over 40 million Americans could lose access to federal food assistance Saturday if the government shutdown continues into November. Barring a deal in Congress that would end the stalemate, ...

SEATTLE — As students head back to school and the fall sports season begins, there's growing recognition that athletic programs can do more than just build physical fitness. A local initiative is ...

There is strong bipartisan support for the Energy Star program in Congress, though its status remains in doubt. Bills from the House and Senate Appropriations Committees call for continued funding of ...

The Oklahoma Partnership for School Readiness said 55% of Oklahomans currently live in a childcare desert, including many families in both Tulsa and Oklahoma City. The Oklahoma Strong Start program at ...

Impulse Space plans to provide GEO rideshare missions using its Helios tug. Credit: Impulse Space SALT LAKE CITY — A year after announcing plans to offer rideshare missions to geostationary orbit, ...

Pfizer's beleaguered obesity strategy has hit another setback as the pharma jettisoned its third and final GLP-1 agonist, citing poor data and tough competition. Pfizer's last remaining GLP-1 agonist, ...